Ralf Wilkowski

2.3k total citations · 1 hit paper
48 papers, 1.8k citations indexed

About

Ralf Wilkowski is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ralf Wilkowski has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 16 papers in Cancer Research. Recurrent topics in Ralf Wilkowski's work include Pancreatic and Hepatic Oncology Research (24 papers), Cancer Genomics and Diagnostics (14 papers) and Neuroendocrine Tumor Research Advances (12 papers). Ralf Wilkowski is often cited by papers focused on Pancreatic and Hepatic Oncology Research (24 papers), Cancer Genomics and Diagnostics (14 papers) and Neuroendocrine Tumor Research Advances (12 papers). Ralf Wilkowski collaborates with scholars based in Germany, Netherlands and Italy. Ralf Wilkowski's co-authors include Volker Heinemann, P Stieber, Stefan Holdenrieder, Andreas Schalhorn, Christiane J. Bruns, Stefan Boeck, Martin Thoma, Axel Hinke, D. Quietzsch and Caroline Haag and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Ralf Wilkowski

46 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Phase III Trial of Gemcitabine Plus Cisplatin Compared With Gemcitabine Alone in Advanced Pancreatic Cancer

2006 535 citations Volker Heinemann, Andreas Schalhorn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ralf Wilkowski Germany	25	1.3k	533	524	502	448	48	1.8k
Bernd Doerken Germany	10	1.8k 1.4×	672 1.3×	509 1.0×	661 1.3×	729 1.6×	19	2.1k
Katja Lindel Germany	22	708 0.6×	466 0.9×	374 0.7×	358 0.7×	610 1.4×	60	1.9k
Marianne Sinn Germany	15	1.6k 1.2×	601 1.1×	558 1.1×	435 0.9×	673 1.5×	49	1.8k
Robert Marsh United States	24	2.0k 1.6×	1.0k 1.9×	490 0.9×	462 0.9×	1.1k 2.4×	78	2.5k
Heung-Moon Chang South Korea	25	1.4k 1.1×	908 1.7×	284 0.5×	261 0.5×	673 1.5×	79	2.1k
C.J. van Groeningen Netherlands	22	1.1k 0.9×	590 1.1×	208 0.4×	222 0.4×	1.0k 2.3×	49	2.4k
Osamu Kainuma Japan	20	1.6k 1.2×	789 1.5×	310 0.6×	412 0.8×	983 2.2×	80	2.1k
Ming‐Chu Chang Taiwan	26	847 0.7×	284 0.5×	320 0.6×	367 0.7×	854 1.9×	69	1.9k
Roger K.C. Ngan China	18	945 0.7×	491 0.9×	242 0.5×	377 0.8×	826 1.8×	43	2.1k
Frédèric Selle France	24	1.4k 1.1×	599 1.1×	238 0.5×	240 0.5×	940 2.1×	127	2.4k

Countries citing papers authored by Ralf Wilkowski

Since Specialization

Citations

This map shows the geographic impact of Ralf Wilkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Wilkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Wilkowski more than expected).

Fields of papers citing papers by Ralf Wilkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Wilkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Wilkowski. The network helps show where Ralf Wilkowski may publish in the future.

Co-authorship network of co-authors of Ralf Wilkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Wilkowski. A scholar is included among the top collaborators of Ralf Wilkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Wilkowski. Ralf Wilkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rank, Andreas, Rienk Nieuwland, Verena Pihusch, et al.. (2011). Surveillance of megakaryocytic function by measurement of CD61‐exposing microparticles in allogeneic hematopoietic stem cell recipients. Clinical Transplantation. 25(3). E233–42. 9 indexed citations

Rank, Andreas, Rienk Nieuwland, Anton Köhler, et al.. (2010). Cellular origin of platelet-derived microparticles in vivo. Thrombosis Research. 126(4). e255–e259. 33 indexed citations

Kolligs, Frank T., Mark op den Winkel, Christiane J. Bruns, et al.. (2010). Diagnose und multimodale Therapie des hepatozellulären Karzinoms. Zeitschrift für Gastroenterologie. 48(2). 274–288. 2 indexed citations

Haas, Michael, Rüdiger P. Laubender, P Stieber, et al.. (2010). Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer. Tumor Biology. 31(4). 351–357. 45 indexed citations

Staehler, Michael, Nicolas Haseke, Thomas Städler, et al.. (2010). Feasibility and effects of high-dose hypofractionated radiation therapy and simultaneous multi-kinase inhibition with sunitinib in progressive metastatic renal cell cancer. Urologic Oncology Seminars and Original Investigations. 30(3). 290–293. 32 indexed citations

Holdenrieder, Stefan, Dorothea Nagel, Andreas Schalhorn, et al.. (2008). Clinical Relevance of Circulating Nucleosomes in Cancer. Annals of the New York Academy of Sciences. 1137(1). 180–189. 114 indexed citations

Schirra, Jörg, Christian Graeb, Ulrich Beuers, et al.. (2008). Interdisziplinäre Diagnostik und Therapie von Gallengangskarzinomen. Zeitschrift für Gastroenterologie. 46(1). 58–68. 8 indexed citations

Boeck, Stefan, Ralf Wilkowski, Christiane J. Bruns, et al.. (2007). Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced Pancreatic Cancer. Oncology. 73(3-4). 221–227. 43 indexed citations

Schaffer, Moshe, Birgit Ertl‐Wagner, P.M. Schaffer, et al.. (2006). Feasibility of Photofrin II as a Radiosensitizing Agent in Solid Tumors – Preliminary Results. Oncology Research and Treatment. 29(11). 514–519. 26 indexed citations

10.

Boeck, Stefan, P Stieber, Stefan Holdenrieder, Ralf Wilkowski, & Volker Heinemann. (2006). Prognostic and Therapeutic Significance of Carbohydrate Antigen 19-9 as Tumor Marker in Patients with Pancreatic Cancer. Oncology. 70(4). 255–264. 138 indexed citations

11.

Wichmann, Matthias W., G. Meyer, Martin K. Angele, et al.. (2003). Detrimental Immunologic Effects of Preoperative Chemoradiotherapy in Advanced Rectal Cancer. Diseases of the Colon & Rectum. 46(7). 875–887. 36 indexed citations

12.

Stemmler, Hans‐Joachim, P Stieber, Andreas Schalhorn, et al.. (2003). Are Serial CA 19-9 Kinetics Helpful in Predicting Survival in Patients with Advanced or Metastatic Pancreatic Cancer Treated with Gemcitabine and Cisplatin?. Oncology Research and Treatment. 26(5). 462–467. 57 indexed citations

13.

Wilkowski, Ralf, Martin Thoma, Volker Heinemann, et al.. (2003). Radiochemotherapie mit Gemcitabin und Cisplatin bei Pankreaskarzinom – durchführbar und effektiv. Strahlentherapie und Onkologie. 179(2). 78–86. 25 indexed citations

14.

Rau, H. G., Matthias W. Wichmann, Ralf Wilkowski, et al.. (2002). Chirurgische Therapie des lokal fortgeschrittenen und primär inoperablen Pankreaskarzinoms nach neoadjuvanter präoperativer Radiochemotherapie. Der Chirurg. 73(2). 132–137. 6 indexed citations

15.

Wilkowski, Ralf, Volker Heinemann, & C. Stoffregen. (2001). Gemcitabine (Gemzar<sup>®</sup>) and Radiotherapy - Is It Feasible?. Frontiers of radiation therapy and oncology. 37. 78–83. 1 indexed citations

16.

Schaffer, Moshe, et al.. (2001). Porphyrias Associated with Malignant Tumors: Results of Treatment with Ionizing Irradiation. Oncology Research and Treatment. 24(2). 170–172. 12 indexed citations

17.

Busch, Martin, Ralf Wilkowski, Moshe Schaffer, & E. Dühmke. (2000). Combined chemotherapy, radiotherapy, and immunotherapy for pancreatic carcinoma—A case report. Advances in Therapy. 17(3). 133–139. 3 indexed citations

18.

Willich, Normann, et al.. (1997). Early Results of IORT in the Treatment of Gastric Cancer. Frontiers of radiation therapy and oncology. 31. 157–160. 4 indexed citations

19.

Krämling, H.-J., Ralf Wilkowski, E. Dühmke, et al.. (1996). [Adjuvant intraoperative radiotherapy of stomach carcinoma].. PubMed. 113. 211–3. 9 indexed citations

20.

Schildberg, F. W., et al.. (1995). Intraoperative Strahlentherapie inklusive Afterloadingverfahren in der gastrointestinalen Chirurgie. 11(2). 153–159.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact